Skip to main content

Table 2 Baseline characteristics of patients

From: Relationship between plasma circulating cell-free DNA concentration and treatment outcomes including prognosis in patients with advanced non-small cell lung cancer

Characteristic

M(P25, P75)

WBC

6.74(5.58, 8.35)

NEU

4.38(3.61, 5.96)

LYM

1.59(1.29, 1.99)

NLR

2.85(2.01, 4.07)

BT1 cfDNA

20.62(13.15, 33.17)

BT2 cfDNA

19.65(11.79, 30.06)

BT3 cfDNA

19.80(11.76, 27.62)

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us